These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7657846)

  • 1. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D; D'Hautefeuille B; Scheck F; Mycinsky C; Pruvost P; Peraudeau P
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
    Kühlkamp V; Schmid F; Risler T; Seipel L
    Int J Cardiol; 1991 Apr; 31(1):65-9. PubMed ID: 1906432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A; Bine-Scheck F; Schenowitz A; Domerego JJ; Maraud L; Canler A; Labban N; Viart R; Aubry P; Beruben E
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
    Frances Y; Luccioni R; Delaage M; Donnarel G; Medvedowsky JL; Quiret JC
    Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of cibenzoline and flecainide administered via an intravenous route in reducing auricular arrhythmia].
    Metz D; Chapoutot L; Laudinat JM; Ehrhard V; Taupin JM; Chabert JP; Metivet F; Pollet E; Bajolet A
    Ann Cardiol Angeiol (Paris); 1990 Jan; 39(1):1-6. PubMed ID: 2107784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term low-dose cibenzoline in patients with chronic renal failure undergoing hemodialysis.
    Honda T; Soejima H; Honda T
    Jpn Circ J; 2000 Jan; 64(1):72-5. PubMed ID: 10651210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
    Medvedowsky JL; Bine-Scheck F; Dambrine P; Domerego JJ; Garnier LF; Labaki F; Piechaczyk P; Rouesnel P; Schenowitz A
    Ann Cardiol Angeiol (Paris); 1994 Feb; 43(2):89-96. PubMed ID: 8172484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
    Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients.
    Clementy J; Dulhoste MN; Laiter C; Denjoy I; Dos Santos P
    Am J Cardiol; 1992 Aug; 70(5):44A-49A. PubMed ID: 1509998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
    Piot O; Flammang D; Dambrine P; Cheikel J; Jouannon C; Graux P; Baudouy Y; Bine-Scheck F; Leenhardt A
    Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
    Naccarelli GV; Dorian P; Hohnloser SH; Coumel P
    Am J Cardiol; 1996 Jan; 77(3):53A-59A. PubMed ID: 8607392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of flecainide for prevention of paroxysmal atrial fibrillation and flutter. Danish-Norwegian Flecainide Multicenter Study Group.
    Pietersen AH; Hellemann H
    Am J Cardiol; 1991 Apr; 67(8):713-7. PubMed ID: 1900978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.